Xenon share price logo

Xenon

NASDAQ: XENE

Mid Cap

$36.94

-1.12

(-2.94%)

as on

Xenon Stock Performance

as on September 28, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $36.48
    $38.25
    downward going graph

    1.25%

    Downside

    3.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $35.97
    $72.66
    downward going graph

    2.63%

    Downside

    96.70%

    Upside

    downward going graph

Xenon share price movements today

Previous Close
$38.06
Open
$38.25
Volume
2.2M
Market Cap
$3.5B
Day's Low - High
$36.48 - $38.25
52 Week Low - High
$35.97 - $72.66

Xenon Historical Returns

1 Month Return
-37.01 %
3 Month Return
-32.97 %
1 Year Return
+ 4.22 %
3 Year Return
+ 7.79 %
5 Year Return
+ 152.55 %

Xenon Stock Fundamentals & Key Indicators

Check Xenon market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5B

EPS (TTM)

-4.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.71

Industry PE ratio

-15.36

PEG Ratio

0.2822645998061036

EBITDA

-416.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-43.98%

Xenon Stock Valuation

Track how Xenon P/E has moved over time to understand its valuation trends.

Xenon in the last 5 years

  • Overview

  • Trends

Lowest (-19.04x)

December 31, 2022

Industry (-15.36x)

December 31, 2025

Today (-10.28x)

December 31, 2025

Highest (-10.28x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -10.28x

Xenon vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenon with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$3.5B152.55%-7.710.00%0.00%
StrongBuy$43.9B615.18%-23.130.00%0.00%
Neutral$79.4B-48.24%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B30.25%18.8284.86%0.47%

Stock Returns calculator for Xenon Stock including INR - Dollar returns

The Xenon stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenon investment value today

Current value as on today

₹1,09,447

Returns

₹9,447

(+9.45%)

Returns from Xenon Stock

₹1,150 (+1.15%)

Dollar Impact

₹8,297 (+8.3%)

Analyst Recommendation on Xenon Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.85714285714286% of analysts recommend a 'BUY' rating for Xenon. Average target price of $74.87

Xenon Share Price Target

Get share price movements and forecasts by analysts on Xenon.

What analysts predicted

50.66%UPSIDE

Target Price

$74.87

Current Price

$36.94

Analyzed by

14 Analysts

High

$90

Target

$74.87

Low

$46

Xenon target price $74.87, a slight upside of 50.66% compared to current price of $36.94. According to 14 analysts rating.

Indian Investors' Interest in Xenon Stock

Investment in Xenon Shares on INDmoney has grown by 1757.14% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1757.14% versus previous 30 day period

Search interest for Xenon Stock has increased by 492% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:492% versus previous 30 day period

Xenon Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
7
-
-
-
-
-
Gross Profit
0
-
-
-
7
0
-77
0
-
-
Operating Income
-59
-69
-73
-77
-72
-94
-96
-109
-112
-123
EBITDA
-58
-68
-72
-76
-72
-93
-89
-104
-111
-111
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-47
-58
-63
-69
-64
-85
-90
-104
-104
-111
Income Tax Expense
0
0
0
-3
0
0
0
0
-2
0
Net Income
-47
-57
-62
-65
-65
-84
-90
-105
-102
-110
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Xenon Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
6
32
18
9
-
-
7
Gross Profit
-25
-6
6
32
18
9
-167
-2
4
Operating Income
-32
-38
-42
-31
-78
-129
-214
-279
-373
EBITDA
-30
-32
-39
-27
-78
-127
-210
-235
-342
Interest Expense
-
1
1
0
-
-
-
-
-
Depreciation
0
0
0
0
0
1
3
2
2
Income Before Tax
-30
-34
-41
-29
-78
-125
-182
-238
-344
Income Tax Expense
-
4
0
0
0
0
0
-4
1
Net Income
-30
-34
-41
-28
-78
-125
-182
-234
-345
Net Profit Margin
-8122.83%
0.00%
100.00%
100.00%
100.00%
100.00%
0.00%
0.00%
66.09%

Xenon Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-47
-57
-62
-65
-65
-84
-90
-105
-102
-110
Operating Cash Flow
-46
-32
-49
-54
-61
-64
-71
-81
-88
-95
Investing Cash Flow
-43
110
0
98
34
82
38
62
-407
-331
Financing Cash Flow
-
-
-
12
1
0
2
113
843
0
Change in Cash
-89
77
-49
55
-26
18
-30
94
346
-426

Xenon Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-30
-34
-41
-28
-78
-125
-182
-234
-345
Operating Cash Flow
-28
-34
-4
-48
-69
-98
-145
-181
-279
Investing Cash Flow
24
-28
-66
-16
-246
-296
-117
165
217
Financing Cash Flow
7
111
27
85
447
278
353
12
117
Change in Cash
3
47
-42
20
130
-118
91
-5
56

Mutual Funds that own Xenon Stock

Check out the Mutual Funds with significant holdings in Xenon.

Funds
Holdings
Shares Held
SMALLCAP World Fund Inc
3.616045%
3501794
VANGUARD SPECIALIZED FUNDS
2.763467%
2676154
Fidelity Rutland Square Trust II
2.189564%
2120384
Fidelity Select Portfolios
1.916517%
1855964
Fidelity Securities Fund
1.303675%
1262485

Global Institutional Holdings in Xenon

Funds
Holdings
iShares
4.92%
Richard Driehaus
4.56%
SMALLCAP World Fund Inc
3.62%
VANGUARD SPECIALIZED FUNDS
2.76%
Fidelity Rutland Square Trust II
2.19%

Xenon News & Key Events

  • img

    Today's Timeline - 18 September

    Fri, 03:00 PM

    -

    Deutsche Bank downgrades Xenon to Hold, lowering price target to $46 due to adverse events in studies.

    Fri, 04:10 PM

    -

    Wells Fargo lowers price target to $64, noting risks in major depressive disorder but potential in seizures.

    Fri, 04:50 PM

    -

    Needham lowers price target to $60, citing uncertainty in depression treatment due to adverse effects.

  • img

    Today's Timeline - 18 September

    Fri, 05:00 PM

    -

    TD Cowen claims Xenon's selloff is overdone despite enrollment pause, maintaining a Buy rating.

    Fri, 05:06 PM

    -

    Xenon Pharmaceuticals shares drop 25% after announcing a pause in enrollment for depression treatment studies.

    Fri, 05:15 PM

    -

    Wedbush lowers Xenon's price target to $55, citing enrollment pause in psychiatric studies due to adverse events.

Insights on Xenon

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.51M → 7.5M (in $), with an average increase of 66.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 714.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 98.3% return, outperforming this stock by 93.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, XENE stock has moved down by -38.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -102.30M → -110.73M (in $), with an average decrease of 8.2% per quarter

About Xenon

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1.6 sodium channel, which is undergoing Phase II clinical evaluation for SCN8A developmental and epileptic encephalopathy, alongside investigations for adult focal epilepsy and other potential indications. Furthermore, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase II development. Beyond its internal development, Xenon Pharmaceuticals has established strategic collaborations. This includes a licensing and development agreement with Neurocrine Biosciences, Inc. focused on epilepsy treatments, and a partnership with Flexion Therapeutics, Inc. to advance PCRX301 (also known as XEN402), a Nav1.7 inhibitor, for post-operative pain management. Established in 1996, the company continues its mission to address significant unmet medical needs in neurology.
OrganisationXenon
Headquarters3650 Gilmore Way, Burnaby, BC, V5G 4W8, CA
IndustryBiotechnology
CEOIan C. Mortimer
E-voting on sharesClick here to vote

Key Management of Xenon

Name

Title

Mr. Thomas Patrick Kelly J.D.

Chief Financial Officer

Ms. Andrea DiFabio J.D.

Chief Legal Officer & Corporate Secretary

Dr. Christopher John Kenney M.D.

Chief Medical Officer

Dr. Robin P. Sherrington Ph.D.

Executive Vice President of Strategy & Innovation

Dr. James R. Empfield Ph.D.

Executive Vice President of Drug Discovery

Ms. Colleen Alabiso

Senior Vice President of Corporate Affairs

Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.

President, CEO & Director

Mr. Darren S. Cline M.B.A.

Chief Commercial Officer

Dr. Matthew D. Ronsheim Ph.D.

Chief Operating Officer

Ms. Shelley McCloskey B.A.

Executive Vice President of Human Resources

FAQs

What is Xenon share price today?

Xenon share price today is $36.94 as on at the close of the market. Xenon share today touched a day high of $38.25 and a low of $36.48.

What is the 52 week high and 52 week low for Xenon share?

Xenon share touched a 52 week high of $72.66 on and a 52 week low of $35.97 on . Xenon stock price today i.e. is closed at $36.94,which is 49.16% down from its 52 week high and 2.70% up from its 52 week low.

What is Xenon's market capitalisation today?

Xenon market capitalisation is $0.00T as on .

How to invest in Xenon Stock (XENE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenon on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenon Shares that will get you 0.0406 shares as per Xenon share price of $36.94 per share as on September 28, 2026 at 8:45 am IST.

What is the minimum amount required to buy Xenon Stock (XENE) from India?

Indian investors can start investing in Xenon (XENE) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Xenon stock (as per the Rupee-Dollar exchange rate as on ). Based on Xenon share’s latest price of $36.94 as on September 28, 2026 at 8:45 am IST, you will get 0.2707 shares of Xenon. Learn more about fractional shares .

What are the returns that Xenon has given to Indian investors in the last 5 years?

Xenon stock has given 152.55% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?